📰 Contract Development News
Page 23 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
October 15, 2023
The company has made a cumulative investment of approximately Rs 4,500 crores.
October 12, 2023
FIDELITY ASIAN VALUES PLCFinal Results for the year ended 31 July 2023 ...
October 11, 2023
LUXEMBOURG, October 11, 2023--Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.
October 11, 2023
Indian pharmaceutical companies have immense potential to increase their share in the $1.4 trillion global pharma industry The global pharmaceutical space has witnessed massive evolution in the last three years, following the pressure mounted by the COVID-19 pandemic. Within a short period, India
October 9, 2023
Launch of a strategic reviewMid-term perspectives suspended1PARIS--(BUSINESS WIRE)--Regulatory News:The Board of Directors of EUROAPI (Paris:EAPI) met today to review the most recent full-year 2023 results forecasts. As a result of this review, the company provides the following update2.The full-year 2023 outlook is...
October 8, 2023
The Goldman Sachs Group lowered shares of Shenzhen Hepalink Pharmaceutical Group (OTCMKTS:SHEZF – Free Report) from a neutral rating to a sell rating in a research report sent to investors on Thursday morning, FlyOnTheWall reports. Shenzhen Hepalink Pharmaceutical Group Stock Performance SHEZF opened at $0.72 on Thursday. Shenzhen Hepalink Pharmaceutical Group has a twelve month […]
October 6, 2023
NorthStar Medical Radioisotopes, LLC will suspend manufacturing and commercialization of molybdenum-99 (Mo-99) by the end of 2023, the company announced Thursday.
October 6, 2023
LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--Altasciences is pleased to welcome Angel Reyes as General Manager, Contract Development and Manufacturing Organization (CDMO) Services.Angel joins Altasciences having previously been the Director of Operations at Catalent. He brings to Altasciences over a decade of expe...
October 5, 2023
Kotak Institutional Equities has cut its FY2024-26E EPS estimate for Navin Fluorine, citing possible delays in growth projects. Jefferies has downgraded the stock to hold from buy and reduced the target price to Rs 3,625 from Rs 5,475